Search This Blog

Friday, June 26, 2026

Acadia gets positive EMA CHMP opinion backing EU approval of DAYBU for Rett syndrome

 

Acadia gets positive EMA CHMP opinion backing EU approval of DAYBU for Rett syndrome in patients aged five and older

  • CHMP positive opinion follows re-examination and covers treatment of neurobehavioral symptoms of Rett syndrome with DAYBU.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)